A novel medicinal formulation for inducing an immune response in patients with chronic and recurring infections

摘要

A composition for the treatment of respiratory tract infection (RTI) comprising, a homogenized mixture of at least two serially diluted and potentized substances, as herein described, selected from: 1. Mycobacterium tuberculosis (culture) (strain A), 2. Mycobacterium bovis (culture) (strain B), 3. Mycobacterium microti (culture) (strain C), 4. Mycobacterium African (culture) (strain D), 5. Mycobacterium Lapre (from cultivation on the mouse footpad) (strain E), said dilution being effected in a vehicle selected from a group consisting of normal saline, distilled water and ethyl alcohol (90 to 100%).